NCT00418587 Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE1
NCT00417430 Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies Status COMPLETED Phase PHASE2
NCT00413361 The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS Status COMPLETED Phase PHASE4
NCT00410384 A Study of Belimumab in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE3
NCT00383214 Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) Status TERMINATED Phase PHASE3
NCT00371501 Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus Status COMPLETED Phase PHASE4
NCT00342095 Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study Status COMPLETED Phase N/A
NCT00297284 Memory and Attention Problems in Lupus: New Treatment Trial With Modafinil Status TERMINATED Phase NA
NCT00293072 Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis Status COMPLETED Phase PHASE2
NCT00278590 Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus Status WITHDRAWN Phase PHASE1
NCT00278538 Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT00271934 Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study Status COMPLETED Phase PHASE2
NCT00230035 Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) Status WITHDRAWN Phase PHASE2